A New Cellular Guardian: How DAPL1 Protects Against Age-Related Macular Degeneration
A study published in the Proceedings of the National Academy of Sciences identifies a novel protective mechanism in retinal pigment epithelium (RPE) cells, the primary site of damage in age-related macular degeneration (AMD). The research reveals that the protein DAPL1 acts as a critical brake on a form of inflammatory cell death called PANoptosis by inhibiting the formation of mitochondria-associated endoplasmic reticulum membranes (MAMs) mediated by GRP75. This discovery provides a specific molecular target—the DAPL1-GRP75-MAM axis—that could be therapeutically modulated to prevent RPE cell death and halt the progression of this leading cause of blindness.
Why it might matter to you:
This research directly intersects with the study of cellular aging and tissue-specific degenerative processes. Understanding the molecular switches that control inflammatory cell death pathways like PANoptosis could inform parallel investigations into age-related decline in other critical tissues, such as the ovary. The identification of DAPL1’s role offers a concrete mechanistic framework for exploring how similar regulatory proteins might influence cellular resilience and longevity across different organ systems.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
